Haploidentical vs matched unrelated donor transplantation for acute myeloid leukemia in remission: A prospective comparative study-Reference-Cited by-同舟云学术

Haploidentical vs matched unrelated donor transplantation for acute myeloid leukemia in remission: A prospective comparative study

Published:2020-11-24 Issue:1 Volume:96 Page:98-109
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Cho Byung‐Sik¹²^ORCID,Min Gi‐June¹²,Park Silvia¹²,Park Sung‐Soo¹²^ORCID,Shin Seung‐Hwan³,Yahng Seung‐Ah⁴^ORCID,Jeon Young‐Woo⁵^ORCID,Yoon Jae‐Ho¹²^ORCID,Lee Sung‐Eun¹²^ORCID,Eom Ki‐Seong¹²,Kim Yoo‐Jin¹²,Lee Seok¹²,Min Chang‐Ki¹²,Cho Seok‐Goo¹,Kim Dong‐Wook¹²,Lee Jong Wook¹^ORCID,Kim Myungshin⁶,Kim Yonggoo⁶,Kim Hee‐Je¹²

Affiliation:

1. Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine The Catholic University of Korea Seoul Republic of Korea

2. Leukemia Research Institute, College of Medicine The Catholic University of Korea Seoul Republic of Korea

3. Department of Hematology, Eunpyeong St. Mary's Hospital, College of Medicine The Catholic University of Korea Seoul Republic of Korea

4. Department of Hematology, Incheon St. Mary's Hospital, College of Medicine The Catholic University of Korea Seoul Republic of Korea

5. Department of Hematology, Yeouido St. Mary's Hospital, College of Medicine The Catholic University of Korea Seoul Republic of Korea

6. Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine The Catholic University of Korea Seoul Republic of Korea

Funder

Korea Health Industry Development Institute

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25993

Reference44 articles.

1. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

2. Current Use and Trends in Hematopoietic Cell Transplantation in the United States

3. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report

4. T-cell-replete haploidentical transplantation in acute myeloid leukemia

5. Treatment of High-Risk Acute Leukemia with T-Cell–Depleted Stem Cells from Related Donors with One Fully Mismatched HLA Haplotype

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic hematopoietic cell transplantation from alternative donors in acute myeloid leukemia;Annals of Hematology;2024-08-17

2. Measurable residual disease (MRD)-testing in haematological cancers: A giant leap forward or sideways?;Blood Reviews;2024-08

3. Real-World Challenges of Haplo-Identical Hematopoietic Stem Cell Transplant in a Developing Country: A Single Center Experience;Cureus;2024-05-06

4. Measurable residual disease (MRD)-testing in haematological and solid cancers;Leukemia;2024-04-18

5. Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1;Bone Marrow Transplantation;2024-03-04